Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients

European Journal of Surgical Oncology

Volumn 40, Issue 5, 2014, Pages 529-535

  Passot, G ^a,b   Bakrin, N ^a,b   Roux, A S ^c   Vaudoyer, D ^a   Gilly, F N ^a,b   Glehen, O ^a,b   Cotte, E ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Cytoreductive surgery; Peritoneal carcinomatosis; Quality of life

Indexed keywords

CISPLATIN; IRINOTECAN; MITOMYCIN; OXALIPLATIN;

ADULT; ARTICLE; CARCINOMATOSIS; CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; GASTRO INTESTINAL QUALITY OF LIFE INDEX QUESTIONNAIRE; HUMAN; HYPERTHERMIA; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT HISTORY OF CHEMOTHERAPY; PERITONEAL CARCINOMATOSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; SCORING SYSTEM; STOMA; TREATMENT DURATION;

CYTOREDUCTIVE SURGERY; PERITONEAL CARCINOMATOSIS; QUALITY OF LIFE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA; CISPLATIN; COHORT STUDIES; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MESOTHELIOMA; MIDDLE AGED; MITOMYCIN; NEOPLASMS, MULTIPLE PRIMARY; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PERITONEUM; PROSPECTIVE STUDIES; PSEUDOMYXOMA PERITONEI; QUALITY OF LIFE; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84897444513     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.11.019     Document Type: Article

References (33)

1. B. Sadeghi, C. Arvieux, and O. Glehen et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 2 2000 358 363
2. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1 1995 29 42
3. P.H. Sugarbaker, W.J. Cunliffe, and J. Belliveau et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer Semin Oncol 16 4 Suppl. 6 1989 83 97
4. O. Glehen, F. Kwiatkowski, and P.H. Sugarbaker et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 16 2004 3284 3292
5. O.C.E. Glehen, and F.N. Gilly Résultats de l'association chirurgie de cytoréduction et chimiothérapie intrapéritonéale dans les carcinoses digestives Arnette, Paris D. Elias, O. Glehen, F.N. Gilly, Rapport de l'association francaise de chirurgie sur les carcinoses péritonéales d'origine digestive et primitive 2008 69 78
6. T.D. Yan, L. Welch, D. Black, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol 18 5 2007 827 834
7. P.H. Sugarbaker New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 1 2006 69 76
8. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol;28(1):63-68.
9. Bakrin N, Cotte E, Golfier F, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a Multicenter, prospective study of 246 patients. Ann Surg Oncol.
10. D. Baratti, S. Kusamura, and M. Deraco The Fifth International Workshop on peritoneal surface malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus J Surg Oncol 98 4 2008 258 262
11. Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer;116(24):5608-5618.
12. G. Glockzin, H.J. Schlitt, and P. Piso Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy World J Surg Oncol 7 2009 5
13. P. Jacquet, and P.H. Sugarbaker Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 1996 359 374
14. O. Glehen, and F.N. Gilly Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma Surg Oncol Clin N Am 12 3 2003 649 671
15. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2 2004 205 213
16. K. Slim, J. Bousquet, and F. Kwiatkowski et al. First validation of the French version of the gastrointestinal quality of life index (GIQLI) Gastroenterol Clin Biol 23 1 1999 25 31
17. Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with Perioperative Intraperitoneal Chemotherapy. Ann Surg Oncol.
18. Quenet F, Goere D, Mehta SS, et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg;254(2):294-301.
19. C.Z.F. Eveno, S. Dagois, J. Mateo, A. Boschetto, and M. Pocard Morbi-mortalité et qualité de vie associées au traitement par CHIP: données de la littérature permettant d'exposer aux patients et aux praticiens les risques immédiats et à long terme Monographie de l'association francaise de chirurgie 2008 61 65
20. T.M. Tuttle, Y. Zhang, E. Greeno, and A. Knutsen Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 13 12 2006 1627 1632
21. R.P. McQuellon, B.W. Loggie, and R.A. Fleming et al. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis Eur J Surg Oncol 27 1 2001 65 73
22. R.P. McQuellon, S.C. Danhauer, and G.B. Russell et al. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis Ann Surg Oncol 14 3 2007 1105 1113
23. Alves S, Mohamed F, Yadegarfar G, et al. Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Eur J Surg Oncol;36(12):1156-1161.
24. A. Macri, I. Maugeri, and G. Trimarchi et al. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome In Vivo 23 1 2009 147 150
25. Hill AR, McQuellon RP, Russell GB, et al. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol;18(13):3673- 3679.
26. R.P. McQuellon, B.W. Loggie, and A.B. Lehman et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis Ann Surg Oncol 10 2 2003 155 162
27. Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive surgery and hyperthermic Intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol.
28. U. Schmidt, M.H. Dahlke, and J. Klempnauer et al. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Eur J Surg Oncol 31 1 2005 53 58
29. F. Zenasni, M. Botella, and D. Elias et al. The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional study Support Care Cancer 17 10 2009 1255 1261
30. J.M. Hannoun-Levi Treatment of breast and uterus cancer: physiological and psychological impact on sexual function Cancer Radiother 9 3 2005 175 182
31. E. Eypasch, J.I. Williams, and S. Wood-Dauphinee et al. Gastrointestinal quality of life index: development, validation and application of a new instrument Br J Surg 82 2 1995 216 222
32. D. Korolija, S. Sauerland, and S. Wood-Dauphinee et al. Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European association for endoscopic surgery Surg Endosc 18 6 2004 879 897
33. W. Schwenk, J. Neudecker, and O. Haase et al. Comparison of EORTC quality of life core questionnaire (EORTC-QLQ-C30) and gastrointestinal quality of life index (GIQLI) in patients undergoing elective colorectal cancer resection Int J Colorectal Dis 19 6 2004 554 560